Antimicrobial Medical Devices
Polaron Medical is building a diversified catalog of antimicrobial medical devices for global distribution, powered by patent-protected technology. No chemicals, no metals, no antibiotics.
of hospital-acquired UTIs are linked directly to catheters
U.S. Centers for Disease Control and Prevention, Accessed 04/16/2026
average cost per CAUTI episode — not reimbursed by CMS
Agency for Healthcare Research and Quality, Accessed 06/14/2026
The Problem
Hospital-acquired infections represent one of the most prevalent, costly, and preventable threats in modern healthcare. Existing solutions are insufficient, and hospitals pay the price.
The Centers for Medicare & Medicaid Services does not reimburse hospitals for CAUTI-related treatment costs, making every infection a direct financial loss.
Hospitals ranking in the bottom 25% for infection rates face a mandatory 1% reduction on all Medicare payments under the Hospital-Acquired Condition Reduction Program. This translates to millions in penalties for large health systems.
Current options may carry biocompatibility concerns, promote antibiotic resistance, and offer limited durability.
Our Mission
Across the entire U.S. healthcare system, over 1 million HAIs occur annually. Hospitals face millions of dollars in non-reimbursable costs and penalties. Preventing HAIs is a top priority for CDC1, and is the reason Polaron Medical exists. We integrate proprietary antimicrobial technology either directly into the structural materials of medical devices, or as a coating.
We are building a diversified catalog of antimicrobial medical devices for global distribution. We are starting with the Foley catheter, the single largest driver of CAUTIs.
1 U.S. Centers for Disease Control and Prevention, Accessed 06/14/2026.
Contact
Whether you're a hospital system, distribution partner, investor, or clinical collaborator, we want to hear from you.
Send a Message